Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

NCT02572609 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02572609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02572609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride
Lead sponsor
Boehringer Ingelheim
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2011
Completion date
December 31, 2011
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy